Wells Fargo Maintains Overweight on HealthEquity, Raises Price Target to $107
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stan Berenshteyn maintains an Overweight rating on HealthEquity (NASDAQ:HQY) and raises the price target from $105 to $107.
June 04, 2024 | 3:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo analyst Stan Berenshteyn maintains an Overweight rating on HealthEquity and raises the price target from $105 to $107.
The Overweight rating and increased price target from a reputable analyst at Wells Fargo are likely to positively influence investor sentiment and drive short-term price appreciation for HealthEquity.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100